Laboratory testing and renal biopsy confirmed the comorbid diagnosis of IgG4-RD and AAV. The following treatments were administered to the patient: In spite of using immunosuppressive therapy, the ...

1 The kidney is one of the most commonly involved organs in AAV. With the initiation of immunosuppressive therapy, the prognosis of AAV has been improved greatly. However, approximately 25% of ...

The patient developed SRH during immunosuppressive therapy but recovered following conservative treatment. We then conducted a systematic literature review on SRH in the context of AAV, and analyzed ...

Read more about the pathophysiology of AAV Treatment varied, with glucocorticoids prescribed to 82.6% of patients and immunosuppressants to 65.2%. Rituximab and mycophenolate were the most commonly ...

sPD-1 in AAV was significantly higher compared with HC (3227±2537 ... The authors suggested that downregulation of PD-1 in regulatory T-cells abrogates the immunosuppressive activity of these cells ...

Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...

First, more than 90% of patients with AAV analysed were prevalent cases. This may limit the generalisability of their findings to incident cases in whom there has been no prior treatment with ...

AMT-130 consists of an adeno-associated virus (AAV) vector carrying a micro-RNA ... of the Huntington’s treatment looking at the use of immunosuppressants in combination with the gene therapy ...

After transplant, the 10 subjects in the study will take immunosuppressant drugs to prevent ... will involve using an adeno-associated virus (AAV) vector to deliver a gene for human glial cell ...